FDA dodges the bullet
Within a few weeks, you'll start hearing a lot of mostly well-intentioned sounds about FDA reform emanating from Washington. But in the end they may signify very little.
As much as it is needed - or perhaps because it is much needed - substantial FDA reform is not likely to happen this year. And next year, all federal legislation will be hostage to presidential politics.
There is, however, some momentum behind congressional efforts to fundamentally change the FDA. The House Commerce Committee's staff, prodded by chairman Thomas J. Bliley, R-Va., the tobacco